Life Science REIT (LON:LABS – Get Free Report) had its target price dropped by stock analysts at Jefferies Financial Group from GBX 45 ($0.59) to GBX 36 ($0.47) in a report issued on Friday, LSE.Co.UK reports. The brokerage presently has a “hold” rating on the stock. Jefferies Financial Group’s target price would indicate a potential upside of 5.88% from the company’s current price.
Life Science REIT Stock Performance
Shares of LABS stock opened at GBX 34 ($0.45) on Friday. The firm has a market cap of £119.00 million, a price-to-earnings ratio of -566.67 and a beta of 0.07. Life Science REIT has a 52 week low of GBX 32.20 ($0.42) and a 52 week high of GBX 76.80 ($1.01). The firm’s 50-day simple moving average is GBX 34.15 and its two-hundred day simple moving average is GBX 37.66.
Read More
- Five stocks we like better than Life Science REIT
- Find and Profitably Trade Stocks at 52-Week Lows
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- Manufacturing Stocks Investing
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Dell Can Continue Winning in AI and Beyond
Receive News & Ratings for Life Science REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life Science REIT and related companies with MarketBeat.com's FREE daily email newsletter.
